Rui Henrique received his MD from the Abel Salazar Institute of Biomedical Sciences of the University of Porto (ICBAS-UP) in 1992. In 2001, after completing a residency in Anatomic Pathology at the Portuguese Oncology Institute of Porto (IPO-Porto), subspecializing in Hematopathology and Uropathology, he became an attending pathologist. In 2006 he became Director of the Department of Pathology. He received his Ph.D. in Medical Sciences (Molecular Pathology) from ICBAS-UP (2006), in cooperation with Johns Hopkins University, USA. In 2011, he obtained the academical title of “Aggregate” in Pathology and Molecular Genetics (ICBAS-UP). He is an invited Full Professor of Pathology and Oncobiology at ICBAS-UP. His research interests focus on the characterization of epigenetic alterations in urological cancer and their translation into novel cancer biomarkers. He has authored and co-authored more than 170 publications in international peer-reviewed scientific periodicals. He joined the Editorial Board of BMC Clinical Pathology in 2014.